Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Variation in the Level of Thyroid Markers in Association with Inflammation in Patients with Type 2 Diabetes

Author(s): Khalid Siddiqui*, Teena P. George , Salini Scaria Joy and Muhammad Mujammami

Volume 20, Issue 6, 2020

Page: [924 - 929] Pages: 6

DOI: 10.2174/1871530319666191125150929

Price: $65

Abstract

Background: A possible relationship between thyroid hormones and glucose metabolism in diabetes has already been established.

Objectives: We aimed to evaluate the thyroid function markers and their relationship with inflammation, which is considered as a pathogenic condition of diabetes.

Methods: This cross-sectional study included 276 patients with type 2 diabetes. Serum levels of thyroid (TSH, FT4, and FT3) and inflammatory markers (CRP, IL-6, and TNF-α) were measured.

Results: The mean age of the subjects was 55.2 years and mean diabetes duration of 16.8 years. The inflammatory markers showed significant differences with the tertiles of TSH and thyroid hormones. TSH was significantly correlated with inflammatory markers, IL-6 (r = 0.13, P = 0.020) and TNF-α (r = 0.17, P = 0.003), while FT4 had a correlation only with TNF-α (r = 0.25, P = <0.001). FT3 was negatively correlated with inflammatory marker IL-6 (r = -0.14, P = 0.020), HbA1c (r = -0.12, P = 0 .040), and HOMA-IR (r = -0.17, P = 0.010).

Conclusion: Abnormalities in the thyroid hormone metabolism are related to the increased inflammatory activity as well as insulin resistance, and are associated with the disorders of glucose metabolism.

Keywords: Type 2 diabetes, thyroid hormones, inflammatory markers, insulin resistance, glucose metabolism, thyroid function.

« Previous Next »
Graphical Abstract

[1]
International Diabetes Federation. IDF diabetes atlas - 2017 Atlas. Available at:, http://www.diabetesatlas.org/resources/2017-atlas.html (Accessed on November 20, 2017).
[2]
Hage, M.; Zantout, M.S.; Azar, S.T. Thyroid disorders and diabetes mellitus. J. Thyroid Res., 2011, 2011,439463.
[http://dx.doi.org/10.4061/2011/439463] [PMID: 21785689]
[3]
Akbar, D.H.; Ahmed, M.M.; Al-Mughales, J. Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics. Acta Diabetol., 2006, 43(1), 14-18.
[http://dx.doi.org/10.1007/s00592-006-0204-8] [PMID: 16710644]
[4]
Wadud, S.; Ahmad, M.; Khan, F. Relationship of Glycemic Control with Thyroid Hormone Levels in Patients with Type 2 Diabetes Mellitus. J. Postgrad. Med. Inst. Peshawar-Pak., 2017, 31(4), 353-356.
[5]
Rochon, C.; Tauveron, I.; Dejax, C.; Benoit, P.; Capitan, P.; Fabricio, A.; Berry, C.; Champredon, C.; Thieblot, P.; Grizard, J. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin. Sci. Lond. Engl.1979,, 1979,104(1) , 7-15..http://dx.doi.org/10.1042
[6]
Dimitriadis, G.; Mitrou, P.; Lambadiari, V.; Boutati, E.; Maratou, E.; Panagiotakos, D.B.; Koukkou, E.; Tzanela, M.; Thalassinos, N.; Raptis, S.A. Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab., 2006, 91(12), 4930-4937.
[http://dx.doi.org/10.1210/jc.2006-0478] [PMID: 17003097]
[7]
Roos, A.; Bakker, S.J.L.; Links, T.P.; Gans, R.O.B.; Wolffenbuttel, B.H.R. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab., 2007, 92(2), 491-496.
[http://dx.doi.org/10.1210/jc.2006-1718] [PMID: 17090642]
[8]
Maratou, E.; Hadjidakis, D.J.; Kollias, A.; Tsegka, K.; Peppa, M.; Alevizaki, M.; Mitrou, P.; Lambadiari, V.; Boutati, E.; Nikzas, D.; Tountas, N.; Economopoulos, T.; Raptis, S.A.; Dimitriadis, G. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur. J. Endocrinol., 2009, 160(5), 785-790.
[http://dx.doi.org/10.1530/EJE-08-0797] [PMID: 19141606]
[9]
Visser, W.E.; Heemstra, K.A.; Swagemakers, S.M.A.; Ozgür, Z.; Corssmit, E.P.; Burggraaf, J.; van Ijcken, W.F.J.; van der Spek, P.J.; Smit, J.W.A.; Visser, T.J. Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts. J. Clin. Endocrinol. Metab., 2009, 94(9), 3487-3496.
[http://dx.doi.org/10.1210/jc.2009-0782] [PMID: 19567520]
[10]
Gómez-Zamudio, J.H.; Mendoza-Zubieta, V.; Ferreira-Hermosillo, A.; Molina-Ayala, M.A.; Valladares-Sálgado, A.; Suárez-Sánchez, F.; de Jesús Peralta-Romero, J.; Cruz, M. High thyroid-stimulating hormone levels increase proinflammatory and cardiovascular markers in patients with extreme obesity. Arch. Med. Res., 2016, 47(6), 476-482.
[http://dx.doi.org/10.1016/j.arcmed.2016.10.007] [PMID: 27986128]
[11]
Rozing, M.P.; Westendorp, R.G.J.; Maier, A.B.; Wijsman, C.A.; Frölich, M.; de Craen, A.J.M.; van Heemst, D. Serum triiodothyronine levels and inflammatory cytokine production capacity. Age (Dordr.), 2012, 34(1), 195-201.
[http://dx.doi.org/10.1007/s11357-011-9220-x] [PMID: 21350816]
[12]
Moura Neto, A.; Parisi, M.C.R.; Tambascia, M.A.; Alegre, S.M.; Pavin, E.J.; Zantut-Wittmann, D.E. The influence of body mass index and low-grade systemic inflammation on thyroid hormone abnormalities in patients with type 2 diabetes. Endocr. J., 2013, 60(7), 877-884.
[http://dx.doi.org/10.1507/endocrj.EJ13-0030] [PMID: 23558976]
[13]
Moura Neto, A.; Parisi, M.C.R.; Alegre, S.M.; Pavin, E.J.; Tambascia, M.A.; Zantut-Wittmann, D.E. Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus. Endocrine, 2016, 51(1), 63-71.
[http://dx.doi.org/10.1007/s12020-015-0651-5] [PMID: 26049370]
[14]
Al-Rubeaan, K.; Siddiqui, K.; Al-Ghonaim, M.A.; Youssef, A.M.; Al-Sharqawi, A.H.; AlNaqeb, D. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients. Sci. Rep., 2017, 7(1), 2684.
[http://dx.doi.org/10.1038/s41598-017-02421-9]
[15]
Levey, A.S.; Stevens, L.A.; Schmid, C.H.; Zhang, Y.L.; Castro, A.F., III; Feldman, H.I.; Kusek, J.W.; Eggers, P.; Van Lente, F.; Greene, T.; Coresh, J. A new equation to estimate glomerular filtration rate. Ann. Intern. Med., 2009, 150(9), 604-612.
[http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006] [PMID: 19414839]
[16]
Mullur, R.; Liu, Y-Y.; Brent, G.A. Thyroid hormone regulation of metabolism. Physiol. Rev., 2014, 94(2), 355-382.
[http://dx.doi.org/10.1152/physrev.00030.2013] [PMID: 24692351]
[17]
Shah, S.N. Thyroid disease in diabetes mellitus. J. Assoc. Physicians India, 1984, 32(12), 1057-1059.
[PMID: 6526798]
[18]
Gursoy, N.T.; Tuncel, E.; Erturk, E.; Imamoglu, S.; Arinik, A. The relationship between the glycemic control and the hypothalamus-pituitary-thyroid axis in diabetic patients. Turk. J. Endocrinol. Metab., 1999, 4, 163-168.
[19]
Peeters, R.P.; Visser, T.J. Metabolism of Thyroid Hormone. In Endotext [Internet];; Feingold, K.R.; Anawalt, B.; Boyce, A.;Chrousos, G.; Dungan, K.; Grossman, A.; Hershman, J.M.; Kaltsas,G.; Koch, C.; Kopp, P.; Korbonits, M.; McLachlan, R.; Morley,J.E.; New, M.; Perreault, L.; Purnell, J.; Rebar, R.; Singer, F.;Trence D.L.; Vinik, A.; Wilson, D.P, Ed.;. South Dartmouth (MA):MDText.com, Inc.;, 2000..
[20]
Mastorakos, G.; Pavlatou, M. Exercise as a stress model and the interplay between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axes. Horm. Metab. Res., 2005, 37(9), 577-584.
[http://dx.doi.org/10.1055/s-2005-870426] [PMID: 16175498]
[21]
Davies, P.H.; Sheppard, M.C.; Franklyn, J.A. Regulation of type I 5′-deiodinase by thyroid hormone and dexamethasone in rat liver and kidney cells. Thyroid, 1996, 6(3), 221-228.
[http://dx.doi.org/10.1089/thy.1996.6.221] [PMID: 8837330]
[22]
Kwakkel, J.; Wiersinga, W.M.; Boelen, A. Differential involvement of nuclear factor-kappaB and activator protein-1 pathways in the interleukin-1beta-mediated decrease of deiodinase type 1 and thyroid hormone receptor beta1 mRNA. J. Endocrinol., 2006, 189(1), 37-44.
[http://dx.doi.org/10.1677/joe.1.06354] [PMID: 16614379]
[23]
Jakobs, T.C.; Mentrup, B.; Schmutzler, C.; Dreher, I.; Köhrle, J. Proinflammatory cytokines inhibit the expression and function of human type I 5′-deiodinase in HepG2 hepatocarcinoma cells. Eur. J. Endocrinol., 2002, 146(4), 559-566.
[http://dx.doi.org/10.1530/eje.0.1460559] [PMID: 11916626]
[24]
Wang, J.; Li, H.; Tan, M.; Gao, G.; Zhang, Y.; Ding, B.; Su, X.; Kong, X.; Ma, J. Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China. Oncotarget, 2019, 10(2), 88-97.
[http://dx.doi.org/10.18632/oncotarget.26265] [PMID: 30719205]
[25]
Aksoy, N.; Yeler, M.T.; Ayan, N.N.; Ozkeskin, A.; Ozkan, Z.; Serin, N.O. Association between thyroid hormone levels and insulin resistance and body mass index. Pak. J. Med. Sci., 2015, 31(6), 1417-1420.
[http://dx.doi.org/10.12669/pjms.316.7560] [PMID: 26870107]
[26]
Kim, S.R.; Tull, E.S.; Talbott, E.O.; Vogt, M.T.; Kuller, L.H. A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis. Med. Hypotheses, 2002, 59(6), 660-666.
[http://dx.doi.org/10.1016/S0306-9877(02)00211-6] [PMID: 12445506]
[27]
Jali, M.V.; Kambar, S.; Jali, S.M.; Pawar, N.; Nalawade, P. Prevalence of thyroid dysfunction among type 2 diabetes mellitus patients. Diabetes Metab. Syndr., 2017, 11(Suppl. 1), S105-S108.
[http://dx.doi.org/10.1016/j.dsx.2016.12.017] [PMID: 28057505]

Rights & Permissions Print Cite
Article Metrics
18
2
© 2024 Bentham Science Publishers | Privacy Policy